These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18473227)

  • 1. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers.
    Liu K; Sun J; Wang Y; He Y; Gao K; He Z
    Drug Dev Ind Pharm; 2008 May; 34(5):465-71. PubMed ID: 18473227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
    Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
    Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X; Gan Y; Gan L; Nie S; Pan W
    J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp].
    Pu XH; Sun J; Qin YM; Zhang X; Zhang P; He ZG
    Yao Xue Xue Bao; 2011 Jul; 46(7):834-8. PubMed ID: 22010354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and characterization of hydroxycamptothecin nanoparticles of amphiphilic block copolymer].
    Xi N; Hou LB
    Zhong Yao Cai; 2009 Apr; 32(4):604-7. PubMed ID: 19645250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
    Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers].
    Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK
    Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles].
    Xi N; Hou LB
    Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro evaluation of an ultrasound-triggered drug delivery system: 10-hydroxycamptothecin loaded PLA microbubbles.
    Hou Z; Li L; Zhan C; Zhu P; Chang D; Jiang Q; Ye S; Yang X; Li Y; Xie L; Zhang Q
    Ultrasonics; 2012 Sep; 52(7):836-41. PubMed ID: 22542992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
    Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
    Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
    J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers.
    Negi LM; Jaggi M; Talegaonkar S
    Int J Pharm; 2014 Jan; 461(1-2):403-10. PubMed ID: 24345574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers.
    Wang Z; Wang J; Yang S; Hou S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
    Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
    Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
    Han M; Liu X; Guo Y; Wang Y; Wang X
    Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of 10-hydroxycamptothecin semisolid lipid nanoparticles and investigation of its stability].
    Xi N; Hou LB; Yan XQ; Jiang QF; Wang CX
    Zhong Yao Cai; 2006 Jan; 29(1):63-6. PubMed ID: 16722323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.